Vista Pharmaceuticals files ANDA for cardiac drug to USFDA

26 Sep 2017 Evaluate

Vista Pharmaceuticals has submitted an Abbreviated New Drug Application (ANDA) to US Food and Drug Administration (USFDA) on September 25, 2017 for a cardiac drug. This project is partnered with an US based company.

Recently, the company’s formulation facility at APIIC Industrial Estate, Nalgonda District in state of Telangana, which was inspected by US Food & Drug Administration (USFDA) during September 2016, had received Establishment Inspection Report (EIR), thereby confirming the closure of the inspection.

Vista Pharmaceuticals is engaged in manufacturing and selling of pharmaceutical, medical and veterinary preparations. The company also sells the products to its related companies, which are engaged in the manufacture of formulations.


Vista Pharma Share Price

7.50 0.12 (1.63%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×